Exchange: NASDAQ·Updated 06:09 PM EST

CTSO News

News
all
press releases
CytoSorbents Announces $6.25 Mln Stock Financing; Agrees With Avenue Capital On A Debt Amendment
(RTTNews) - CytoSorbents Corp. (CTSO), a medical device company specializing in blood purification technologies, Friday announced a $6.25 million stock financing and an agreement with Avenue Capital Group to reduce debt and extend its loan maturity...
Nasdaq News: Markets
CytoSorbents Announces $6.25 Mln Stock Financing; Agrees With Avenue Capital On A Debt Amendment
(RTTNews) - CytoSorbents Corp. (CTSO), a medical device company specializing in blood purification technologies, Friday announced a $6.25 million stock financing and an agreement with Avenue Capital Group to reduce debt and extend its loan maturity...
Nasdaq News: Markets
More News
CytoSorbents Announces $6.25 Million Common Stock Financing Priced At-the-Market under Nasdaq Rules and Concurrent Restructuring of Avenue Capital Credit Facility CytoSorbents Announces $6.25 Million Common Stock Financing Priced At-the-Market under Nasdaq Rules and Concurrent Restructuring of...
PR Newswire
Cytosorbents Corporation 2026 Q3 - Results - Earnings Call Presentation...
SeekingAlpha
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
CytoSorbents Reports Third Quarter 2026 Financial Results, Achieves Operating Cash Flow Breakeven, and Provides Business and Regulatory Update CytoSorbents Reports Third Quarter 2026 Financial Results, Achieves Operating Cash Flow Breakeven, and Provides Business and Regulatory UpdatePR...
PR Newswire
CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in London CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in LondonPR NewswirePRINCETON, N.J., Nov. 9, 2026 PRINCETON, N.J., Nov. 9, 2026 /PRNewswire/ -- CytoSorbents Corporation(NASDAQ...
PR Newswire
CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business HighlightsPR NewswirePRINCETON, N.J., Oct. 29, 2026 PRINCETON, N.J., Oct. 29, 2026 /PRNewswire/ -- CytoSorbents...
PR Newswire
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical CarePR NewswirePRINCETON, N.J., Sept. 30, 2026PRINCETON, N.J...
PR Newswire
CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price RequirementPR NewswirePRINCETON, N.J., Sept. 23, 2026 PRINCETON, N.J., Sept. 23, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the...
PR Newswire
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference PR Newswire PRINCETON, N.J., Sept. 10, 2026 PRINCETON, N.J., Sept. 10, 2026 /PRNewswire/ -- CytoSorbents...
PR Newswire

Advertisement|Remove ads.